Insulin Glargine
-
Subject Areas on Research
- A primer on concentrated insulins: what an internist should know.
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE).
- Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes.
- Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.
- Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
- Improved glycemic control enhances the incretin effect in patients with type 2 diabetes.
- Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
- Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
- Web-Based Management Trial of Diabetes Care.
- Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.